IN BRIEF: GSK Chair Jonathan Symonds buys GBP53,000 in shares
GSK PLC - London-based pharmaceuticals company - GSK Non-Executive Chair Jonathan Symonds buys 2,500 shares, at a price of GBP21.14, worth GBP52,850, on Thursday in London. Read More
| Price | 2,210.00p on 09-02-2026 at 08:02:35 |
|---|---|
| Change | 12.00p 0.55% |
| Buy | 2,211.00p |
| Sell | 2,210.00p |
| Last Trade: | Sell 113.00 at 2,210.00p |
| Day's Volume: | 219,453 |
| Last Close: | 2,198.00p |
| Open: | 2,200.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,197.00p - 2,211.00p |
| 52wk Range: | 1,242.50p - 2,211.00p |
| Market Capitalisation: | £88.69b |
| VWAP: | 2,200.57613p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 113 | 2,210.00p | Automatic Execution |
08:02:35 - 09-Feb-26 |
| Sell* | 120 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Sell* | 280 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Sell* | 100 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 28 | 2,211.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 119 | 2,211.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 815 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 924 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 170 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
| Buy* | 267 | 2,210.00p | Automatic Execution |
08:02:32 - 09-Feb-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Feb 2026 10:30 am | RNS | Director/PDMR Shareholding |
| 6th Feb 2026 7:00 am | RNS | Nucala COPD approved by the European Commission |
| 5th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 4th Feb 2026 7:00 am | RNS | Final Results |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 26th Jan 2026 7:00 am | RNS | European Commission approves Arexvy for adults 18+ |
| 20th Jan 2026 7:05 am | RNS | GSK to acquire RAPT Therapeutics |
| 20th Jan 2026 7:00 am | RNS | Agreement on changes to ViiV minority shareholding |
| 16th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |